Literature DB >> 15324477

Efficacy of chitosan microspheres for controlled intra-articular delivery of celecoxib in inflamed joints.

Hetal Thakkar1, R K Sharma, A K Mishra, Krishna Chuttani, R S R Murthy.   

Abstract

The use of polymeric carriers in formulations of therapeutic drug delivery systems has gained widespread application, due to their advantage of being biodegradable and biocompatible. In this study, we aimed to prepare celecoxib-loaded chitosan microspheres for intra-articular administration and to compare the retention of the celecoxib solution and chitosan microspheres in the joint cavity. The microspheres were characterized for entrapment efficiency, particle size and surface morphology by scanning electron microscopy. In-vitro drug release studies of microspheres revealed that the microspheres are able to control the release of celecoxib over a period of 96 h. Biodistribution studies of celecoxib and chitosan microspheres were performed by radiolabelling with( 99m)Tc and injecting intraarticularly in rats. The study indicated that following intra-articular administration the distribution of the drug to the organs, like liver and spleen, is very rapid compared with that of the microspheres. Compared with the drug solution, a 10-fold increase in the concentration of the drug in the joint was observed 24 h post intra-articular injection (P < 0.005) when drug was encapsulated in microspheres.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15324477     DOI: 10.1211/0022357044166

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  9 in total

Review 1.  New dosage formulations for targeted delivery of cyclo-oxygenase-2 inhibitors: focus on use in the elderly.

Authors:  Shyam S Bansal; Abhijeet Joshi; Arvind K Bansal
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

2.  Release and activity of anti-TNFalpha therapeutics from injectable chitosan preparations for local drug delivery.

Authors:  Mohammed F Shamji; Priscilla Hwang; Robert W Bullock; Samuel B Adams; Dana L Nettles; Lori A Setton
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2009-07       Impact factor: 3.368

Review 3.  Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects.

Authors:  Heidi M Mansour; Minji Sohn; Abeer Al-Ghananeem; Patrick P Deluca
Journal:  Int J Mol Sci       Date:  2010-09-15       Impact factor: 5.923

Review 4.  Recent advances in the pharmacological management of pain.

Authors:  Josée Guindon; Jean-Sébastien Walczak; Pierre Beaulieu
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 5.  Emerging intra-articular drug delivery systems for the temporomandibular joint.

Authors:  Paschalia M Mountziaris; Phillip R Kramer; Antonios G Mikos
Journal:  Methods       Date:  2008-10-01       Impact factor: 3.608

6.  Nanoparticles for improved local retention after intra-articular injection into the knee joint.

Authors:  Michael Morgen; David Tung; Britton Boras; Warren Miller; Anne-Marie Malfait; Micky Tortorella
Journal:  Pharm Res       Date:  2012-09-21       Impact factor: 4.200

7.  Drug-Bearing Supramolecular Filament Hydrogels as Anti-Inflammatory Agents.

Authors:  Zhipeng Chen; Lei Xing; Qin Fan; Andrew G Cheetham; Ran Lin; Barbara Holt; Liwen Chen; Yanyu Xiao; Honggang Cui
Journal:  Theranostics       Date:  2017-05-12       Impact factor: 11.556

8.  PPARα-ACOT12 axis is responsible for maintaining cartilage homeostasis through modulating de novo lipogenesis.

Authors:  Sujeong Park; In-Jeoung Baek; Ji Hyun Ryu; Churl-Hong Chun; Eun-Jung Jin
Journal:  Nat Commun       Date:  2022-01-05       Impact factor: 14.919

9.  Cationic PLGA/Eudragit RL nanoparticles for increasing retention time in synovial cavity after intra-articular injection in knee joint.

Authors:  Sung Rae Kim; Myoung Jin Ho; Eugene Lee; Joon Woo Lee; Young Wook Choi; Myung Joo Kang
Journal:  Int J Nanomedicine       Date:  2015-08-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.